• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成纤维细胞生长因子21在预防衰老相关代谢性疾病中的作用及药理效应

The Roles and Pharmacological Effects of FGF21 in Preventing Aging-Associated Metabolic Diseases.

作者信息

Yan Junbin, Nie Yunmeng, Cao Jielu, Luo Minmin, Yan Maoxiang, Chen Zhiyun, He Beihui

机构信息

The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.

Key Laboratory of Integrative Chinese and Western Medicine for the Diagnosis and Treatment of Circulatory Diseases of Zhejiang Province, Hangzhou, China.

出版信息

Front Cardiovasc Med. 2021 Mar 31;8:655575. doi: 10.3389/fcvm.2021.655575. eCollection 2021.

DOI:10.3389/fcvm.2021.655575
PMID:33869312
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8044345/
Abstract

With the continuous improvement of living standards but the lack of exercise, aging-associated metabolic diseases such as obesity, type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD) are becoming a lingering dark cloud over society. Studies have found that metabolic disorders are near related to glucose, lipid metabolism, and cellular aging. Fibroblast growth factor 21 (FGF21), a member of the FGFs family, efficiently regulates the homeostasis of metabolism and cellular aging. By activating autophagy genes and improving inflammation, FGF21 indirectly delays cellular aging and directly exerts anti-aging effects by regulating aging genes. FGF21 can also regulate glucose and lipid metabolism by controlling metabolism-related genes, such as adipose triglyceride lipase (ATGL) and acetyl-CoA carboxylase (ACC1). Because FGF21 can regulate metabolism and cellular aging simultaneously, FGF21 analogs and FGF21 receptor agonists are gradually being valued and could become a treatment approach for aging-associated metabolic diseases. However, the mechanism by which FGF21 achieves curative effects is still not known. This review aims to interpret the interactive influence between FGF21, aging, and metabolic diseases and delineate the pharmacology of FGF21, providing theoretical support for further research on FGF21.

摘要

随着生活水平的不断提高但缺乏运动,肥胖、2型糖尿病(T2DM)和非酒精性脂肪性肝病(NAFLD)等与衰老相关的代谢性疾病正成为笼罩社会的挥之不去的阴霾。研究发现,代谢紊乱与葡萄糖、脂质代谢以及细胞衰老密切相关。成纤维细胞生长因子21(FGF21)是FGFs家族的一员,能有效调节代谢和细胞衰老的稳态。通过激活自噬基因和改善炎症,FGF21间接延缓细胞衰老,并通过调节衰老基因直接发挥抗衰老作用。FGF21还可通过控制与代谢相关的基因,如脂肪甘油三酯脂肪酶(ATGL)和乙酰辅酶A羧化酶(ACC1)来调节葡萄糖和脂质代谢。由于FGF21能同时调节代谢和细胞衰老,FGF21类似物和FGF21受体激动剂正逐渐受到重视,并可能成为治疗与衰老相关代谢性疾病的一种方法。然而,FGF21实现治疗效果的机制仍不清楚。本综述旨在解读FGF21、衰老和代谢性疾病之间的相互影响,并阐述FGF21的药理学,为进一步研究FGF21提供理论支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca2c/8044345/70d9d7ca183c/fcvm-08-655575-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca2c/8044345/6deaae8cc425/fcvm-08-655575-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca2c/8044345/70d9d7ca183c/fcvm-08-655575-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca2c/8044345/6deaae8cc425/fcvm-08-655575-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ca2c/8044345/70d9d7ca183c/fcvm-08-655575-g0002.jpg

相似文献

1
The Roles and Pharmacological Effects of FGF21 in Preventing Aging-Associated Metabolic Diseases.成纤维细胞生长因子21在预防衰老相关代谢性疾病中的作用及药理效应
Front Cardiovasc Med. 2021 Mar 31;8:655575. doi: 10.3389/fcvm.2021.655575. eCollection 2021.
2
FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.成纤维细胞生长因子 21(FGF21)不需要脂肪细胞 AMP 激活的蛋白激酶(AMPK)或乙酰辅酶 A 羧化酶(ACC)的磷酸化来介导全身葡萄糖稳态的改善。
Mol Metab. 2017 Apr 5;6(6):471-481. doi: 10.1016/j.molmet.2017.04.001. eCollection 2017 Jun.
3
The potential function and clinical application of FGF21 in metabolic diseases.成纤维细胞生长因子21(FGF21)在代谢性疾病中的潜在作用及临床应用
Front Pharmacol. 2022 Dec 21;13:1089214. doi: 10.3389/fphar.2022.1089214. eCollection 2022.
4
The role of FGF21 and its analogs on liver associated diseases.成纤维细胞生长因子21(FGF21)及其类似物在肝脏相关疾病中的作用。
Front Med (Lausanne). 2022 Nov 15;9:967375. doi: 10.3389/fmed.2022.967375. eCollection 2022.
5
Fibroblast growth factor 21: An emerging pleiotropic regulator of lipid metabolism and the metabolic network.成纤维细胞生长因子21:脂质代谢及代谢网络中一种新出现的多效性调节因子。
Genes Dis. 2023 Aug 2;11(3):101064. doi: 10.1016/j.gendis.2023.06.033. eCollection 2024 May.
6
Fibroblast growth factor 21 in lipid metabolism and non-alcoholic fatty liver disease.成纤维细胞生长因子 21 在脂代谢及非酒精性脂肪性肝病中的作用
Clin Chim Acta. 2019 Nov;498:30-37. doi: 10.1016/j.cca.2019.08.005. Epub 2019 Aug 13.
7
Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.肝酰基辅酶 A 去饱和酶 1 缺乏症通过 PGC-1α-FGF21 轴部分增加脂肪组织中的葡萄糖摄取。
J Biol Chem. 2019 Dec 20;294(51):19475-19485. doi: 10.1074/jbc.RA119.009868. Epub 2019 Nov 5.
8
Therapeutic Approaches to Alzheimer's Type of Dementia: A Focus on FGF21 Mediated Neuroprotection.阿尔茨海默病类型痴呆症的治疗方法:聚焦 FGF21 介导的神经保护作用。
Curr Pharm Des. 2019;25(23):2555-2568. doi: 10.2174/1381612825666190716101411.
9
Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.Nrg4 可促进燃料氧化和健康的脂肪细胞因子谱,改善饮食诱导的代谢紊乱。
Mol Metab. 2017 Jun 21;6(8):863-872. doi: 10.1016/j.molmet.2017.03.016. eCollection 2017 Aug.
10
Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus.成纤维细胞生长因子 21 作为 2 型糖尿病治疗靶点的新进展。
Med Res Rev. 2016 Jul;36(4):672-704. doi: 10.1002/med.21390. Epub 2016 Mar 31.

引用本文的文献

1
Different association of GDF15 and FGF21 with glycemic status and aging in the context of obesity.在肥胖背景下,生长分化因子15(GDF15)和成纤维细胞生长因子21(FGF21)与血糖状态及衰老的不同关联。
Geroscience. 2025 Aug 19. doi: 10.1007/s11357-025-01830-3.
2
Age: A Moderating Effect on Cerebrospinal Fluid Fibroblast Growth Factor 21 and Cognitive Function.年龄:对脑脊液成纤维细胞生长因子21和认知功能的调节作用
Brain Behav. 2025 Aug;15(8):e70784. doi: 10.1002/brb3.70784.
3
The myokine FGF21 associates with enhanced survival in ALS and mitigates stress-induced cytotoxicity.

本文引用的文献

1
AKR-001, an Fc-FGF21 Analog, Showed Sustained Pharmacodynamic Effects on Insulin Sensitivity and Lipid Metabolism in Type 2 Diabetes Patients.AKR-001,一种 Fc-FGF21 类似物,在 2 型糖尿病患者中显示出持续的胰岛素敏感性和脂代谢药效学作用。
Cell Rep Med. 2020 Jul 21;1(4):100057. doi: 10.1016/j.xcrm.2020.100057.
2
The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic.成纤维细胞生长因子 21 在代谢性疾病中的治疗潜力:从实验室到临床。
Nat Rev Endocrinol. 2020 Nov;16(11):654-667. doi: 10.1038/s41574-020-0386-0. Epub 2020 Aug 6.
3
FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation.
肌动蛋白FGF21与肌萎缩侧索硬化症患者生存率提高相关,并减轻应激诱导的细胞毒性。
Aging (Albany NY). 2025 Aug 9;17(8):2033-2062. doi: 10.18632/aging.206298.
4
Bridging systemic metabolic dysfunction and Alzheimer's disease: the liver interface.连接全身代谢功能障碍与阿尔茨海默病:肝脏的界面
Mol Neurodegener. 2025 May 28;20(1):61. doi: 10.1186/s13024-025-00849-6.
5
Decoding the Liver-Heart Axis in Cardiometabolic Diseases.解读心脏代谢疾病中的肝心轴
Circ Res. 2025 May 23;136(11):1335-1362. doi: 10.1161/CIRCRESAHA.125.325492. Epub 2025 May 22.
6
ADAM10-mediated β-klotho degradation: a key to FGF21 resistance in senescent vascular endothelial cells.ADAM10介导的β-klotho降解:衰老血管内皮细胞中FGF21抵抗的关键
Geroscience. 2024 Dec 9. doi: 10.1007/s11357-024-01463-y.
7
Skin senescence-from basic research to clinical practice.皮肤衰老——从基础研究到临床实践
Front Med (Lausanne). 2024 Oct 18;11:1484345. doi: 10.3389/fmed.2024.1484345. eCollection 2024.
8
Hepatokines and MASLD: The GLP1-Ras-FGF21-Fetuin-A Crosstalk as a Therapeutic Target.肝分泌因子与 MASLD:GLP1-Ras-FGF21-胎球蛋白 A 串扰作为治疗靶点。
Int J Mol Sci. 2024 Oct 8;25(19):10795. doi: 10.3390/ijms251910795.
9
Effect of Fibroblast Growth Factor (FGF) 19 and 21 on Hip Geometry and Strength in Post-menopausal Osteoporosis (PMO).成纤维细胞生长因子 19 和 21 对绝经后骨质疏松症(PMO)髋关节几何结构和强度的影响。
Calcif Tissue Int. 2024 Nov;115(5):562-569. doi: 10.1007/s00223-024-01284-3. Epub 2024 Sep 28.
10
The myokine FGF21 associates with enhanced survival in ALS and mitigates stress-induced cytotoxicity.肌动蛋白FGF21与肌萎缩侧索硬化症患者生存率提高相关,并减轻应激诱导的细胞毒性。
bioRxiv. 2024 Sep 14:2024.09.11.611693. doi: 10.1101/2024.09.11.611693.
成纤维细胞生长因子21调节肝脏代谢途径以改善脂肪变性和炎症。
Endocr Connect. 2020 Aug;9(8):755-768. doi: 10.1530/EC-20-0152.
4
The Aging Metabolome-Biomarkers to Hub Metabolites.衰老代谢组学——标志物到枢纽代谢物。
Proteomics. 2020 Mar;20(5-6):e1800407. doi: 10.1002/pmic.201800407.
5
Pegbelfermin (BMS-986036): an investigational PEGylated fibroblast growth factor 21 analogue for the treatment of nonalcoholic steatohepatitis.培格非格司亭(BMS-986036):一种研究性聚乙二醇化成纤维细胞生长因子 21 类似物,用于治疗非酒精性脂肪性肝炎。
Expert Opin Investig Drugs. 2020 Feb;29(2):125-133. doi: 10.1080/13543784.2020.1708898. Epub 2020 Jan 3.
6
The FGF metabolic axis.FGF 代谢轴。
Front Med. 2019 Oct;13(5):511-530. doi: 10.1007/s11684-019-0711-y. Epub 2019 Sep 7.
7
Deficiency of fibroblast growth factor 21 aggravates obesity-induced atrophic responses in skeletal muscle.成纤维细胞生长因子21缺乏会加重肥胖诱导的骨骼肌萎缩反应。
J Inflamm (Lond). 2019 Jul 4;16:17. doi: 10.1186/s12950-019-0221-3. eCollection 2019.
8
Going Back to the Biology of FGF21: New Insights.回到 FGF21 的生物学:新的见解。
Trends Endocrinol Metab. 2019 Aug;30(8):491-504. doi: 10.1016/j.tem.2019.05.007. Epub 2019 Jun 24.
9
Role of mitochondria in diabetic peripheral neuropathy: Influencing the NAD-dependent SIRT1-PGC-1α-TFAM pathway.线粒体在糖尿病周围神经病变中的作用:影响 NAD 依赖性 SIRT1-PGC-1α-TFAM 通路。
Int Rev Neurobiol. 2019;145:177-209. doi: 10.1016/bs.irn.2019.04.002. Epub 2019 Jun 8.
10
Lipometabolism and Glycometabolism in Liver Diseases.肝脏疾病中的脂代谢和糖代谢。
Biomed Res Int. 2018 Dec 12;2018:1287127. doi: 10.1155/2018/1287127. eCollection 2018.